{
    "_id": "38246166|None",
    "id": "38246166",
    "infons": {},
    "passages": [
        {
            "infons": {
                "journal": "Mol Ther;2024Feb07; 32 (2) 264. doi:10.1016/j.ymthe.2024.01.015",
                "year": "2024",
                "article-id_pmc": "PMC10862012",
                "type": "title",
                "authors": "Leonard A, Tisdale JF, "
            },
            "offset": 0,
            "text": "A new frontier: FDA approvals for gene therapy in sickle cell disease.",
            "sentences": [],
            "annotations": [
                {
                    "id": "1",
                    "infons": {
                        "identifier": "MESH:D000755",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "D000755"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D000755",
                        "biotype": "disease",
                        "name": "Anemia Sickle Cell",
                        "accession": "@DISEASE_Anemia_Sickle_Cell"
                    },
                    "text": "sickle cell disease",
                    "locations": [
                        {
                            "offset": 50,
                            "length": 19
                        }
                    ]
                }
            ],
            "relations": []
        },
        {
            "infons": {
                "type": "abstract"
            },
            "offset": 71,
            "text": "",
            "sentences": [],
            "annotations": [],
            "relations": []
        }
    ],
    "relations": [],
    "pmid": 38246166,
    "pmcid": null,
    "meta": {},
    "date": "2024-02-07T00:00:00Z",
    "journal": "Mol Ther",
    "authors": [
        "Leonard A",
        "Tisdale JF"
    ],
    "relations_display": []
}